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Smoking prevalence in Brazil has almost halved 
over the last two decades. Data from the Brazil-
ian Institute of Geography and Statistics (IBGE) 1 
shows that smoking rates among men and 
women aged 15 years and over fell from 33.1% 
in 1989 to 17.2% in 2008. This fall in smoking 
prevalence has led to substantial improvements 
in public health in Brazil due to the strong as-
sociation between smoking and morbid condi-
tions, such as chronic obstructive pulmonary 
disease (COPD), cancer (lung, larynx and other 
sites), cardiovascular morbidity, and other se-
vere illnesses. Levy et al. 2 estimated that 420,000 
smoking-attributable deaths were prevented up 
to 2010, and as many as seven million projected 
premature deaths will be averted by 2050. This 
public health success story is the result of the im-
plementation of strict tobacco control policies, 
including increases in tobacco taxes and higher 
cigarette prices, smoke-free air laws, tobacco in-
dustry marketing bans, health warnings, mass 
media anti-smoking campaigns and smoking 
cessation treatment programs. It is anticipated 
that the implementation of an additional set of 
stricter policies would cause further reductions 
in tobacco-related morbidity and mortality. Us-
ing simulation modelling, Levy et al. 2 found that 
a further 39% reduction in smoking prevalence 
would prevent 1.3 million of the 9 million pre-
mature deaths projected up to 2050. In light of 
this public health scenario, the Brazilian Health 
Surveillance Agency (ANVISA) has banned most 
flavourings and additives in tobacco products.
Over 600 substances, including flavourings, 
sugars, menthol, humectants, ammonium com-
pounds, cocoa and licorice are currently added 
to tobacco products. Additives are mostly used 
in blended cigarettes consumed in Brazil, the US, 
Latin America, Europe (except in the UK) and a 
number of Asian countries. In China, Canada, the 
UK, Australia, Ireland and some Asian countries, 
Virginia type cigarettes which contain relative-
ly few additives dominate the market. American 
blend cigarettes contain a mixture of tobaccos in-
cluding Burley tobacco, while Virginia cigarettes 
are primarily composed of only one type of to-
bacco. Virginia tobacco is flue-cured (cured over 
a short period of time at high temperatures). The 
curing process inactivates hydrolytic enzymes 
leading to high sugar content. Burley tobacco, on 
the other hand, is cured at lower temperatures for 
long periods (air-curing) resulting in a low sugar 
and high nicotine content. According to the Bra-
zilian Tobacco Industry Association (ABIFUMO), 
additives are used in American blend cigarettes to 
replace the sugar lost during the curing process 
of Burley tobacco and to give the product a con-
sistent taste and aroma and create their own sig-
nature blend. Although ABIFUMO acknowledges 
the existence of additive-free blended cigarettes, 
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it argues that these products are intended for a 
niche market and large scale production is not 
commercially viable.
Many scientists believe that the real purpose 
of using additives in cigarettes goes far beyond 
merely assuring a consistent taste and aroma 
and creating a signature blend: apart from in-
creasing toxicity, adding a complex mixture of 
substances (additives) may increase the addic-
tiveness and attractiveness of a tobacco prod-
uct in terms of product appeal and palatability, 
which in turn is likely to have a strong impact on 
smoking prevalence. 
Industry-sponsored studies addressing the 
effects of mixtures of commonly used additives 
on cigarette smoke chemistry and toxicity con-
cluded that additives have no effect on the lev-
els of chemical components of cigarette smoke 
and toxicity. Since the findings of these studies 
showed that the presence of additives increased 
the levels of total particulate matter (TPM) and 
several toxicants in mainstream smoke, these 
conclusions could only have been reached by ex-
pressing the levels of specific toxicants adjusted 
by TPM concentration. Most importantly, the to-
bacco industry did not carry out long-term stud-
ies or carcinogenicity assays on animals exposed 
by inhalation to specifically test single additives 
and mixtures and their pyrolysis products. There-
fore, in the report (http://s.anvisa.gov.br/wps/
s/r/cXkP, accessed on 13/Jan/2015), the Working 
Group on Tobacco Additives (WG) did not accept 
the tobacco industry’s claims that there is no ev-
idence to show that additives increase the inher-
ent toxicity of tobacco smoke.
Addiction leads to the continued exposure of 
smokers to toxicants, thereby contributing to the 
occurrence of tobacco-related diseases. Moreo-
ver, addiction per se is a medical condition that 
involves compulsive use despite the negative 
health consequences and desire to quit. The cig-
arette is a highly engineered and sophisticated 
nicotine delivery device. Although nicotine plays 
a major role in tobacco addiction, other substanc-
es may also play an important supporting role. In 
theory, additives can enhance the addictiveness 
of the product through increasing the overall 
bioavailability of nicotine by facilitating smoke 
inhalation and thus the absorption of nicotine 
through the lung alveoli, by decreasing nicotine 
clearance (for example due to the inhibition of 
CYP2A6), by changing the properties of tobacco 
smoke, and by enhancing the reinforcing proper-
ties of nicotine (for example monoamine oxidase 
inhibitors). Certain substances added to tobac-
co can cause one or more of these effects. Sugar 
in different forms is one of the most common 
and abundant additives in tobacco products. Al-
though the oral ingestion of sugars is not hazard-
ous to the health, the burning of sugar produces 
toxic aldehydes, one of which (acetaldehyde) has 
been shown to increase the addictiveness of to-
bacco in animal studies. The overall effect of a 
mixture of additives on smoking behaviour ap-
parently depends on the relative amount of each 
component and the complex interaction be-
tween these substances. The addition of sugars, 
for instance, leads to an increase in acid content, 
lowers pH and reduces the harshness of smoke 
from cigarettes with a high nicotine/tar ratio. The 
absorption of nicotine decreases with decreas-
ing smoke pH, while substances that raise smoke 
pH (for example ammonium) facilitate absorp-
tion because the concentration of nicotine in its 
free uncharged form, which is more readily ab-
sorbed than positively charged nicotine, is great-
er at higher pH. Therefore, a balance between the 
combinations of additives is apparently neces-
sary to achieve the intended effect on smoking 
behaviour and product attractiveness.
Both extrinsic factors (for example market-
ing, pricing, packaging) and intrinsic factors 
(for example taste, smell, sensory attributes and 
pharmacological effects) influence the attrac-
tiveness of a tobacco product. Smoking initiation 
is influenced by smell, taste and aroma, smoke 
smoothness and harshness, and perceptions of 
environmental tobacco smoke. Tobacco com-
panies may use additives to alter these charac-
teristics and enhance product palatability and 
promote the misimpression that the resulting 
product is less harmful.
Studies have yet to provide evidence that 
supports the tobacco industry’s allegations that 
additives have no influence on the appeal or at-
tractiveness of tobacco products. A cross-coun-
try comparison between the US (American blend 
tobacco with additives) and Canada (Virginia to-
bacco with no or relatively few additives) which 
showed similar smoking rates in the two coun-
tries was presented by ABIFUMO as evidence 
that additives have no influence on product 
attractiveness. Given the differences between 
the confounding factors in these countries (in-
cluding the type of tobacco used, configuration 
of additives contained in tobacco products and 
historical differences in the development of the 
tobacco market) the WG concluded that this type 
of cross-country comparison did not provide a 
valid measure of the influence of additives on the 
attractiveness of tobacco products.
The tobacco industry used a similar 
cross-country comparison to investigate the in-
fluence of additives on the inherent addictive-
ness of tobacco. Sanders et al. 3 performed a 
meta-analysis of clinical studies addressing the 
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effectiveness of nicotine replacement therapy 
and investigated differences in smoking cessa-
tion rates between countries where the tobacco 
market was dominated by flue-cured cigarettes 
(without additives) and countries where the pre-
dominant product was blended cigarettes (with 
additives). Based on the assumption that the dif-
ficulty of quitting smoking is a valid measure of 
tobacco addictiveness, Sanders et al. 3 concluded 
that additives do not increase cigarette addic-
tiveness because no significant difference in quit 
rates was found between the countries. This sole 
source of evidence on the effect of additives on 
product addictiveness is insufficient since the 
study demonstrated a number of limitations, in-
cluding the lack of consideration of country spe-
cific factors.
The tobacco industry claims that the effects 
of additives on the addictiveness and/or attrac-
tiveness of their products remain undemon-
strated. Upon reviewing the studies provided by 
ABIFUMO and other studies identified through 
a comprehensive literature search, the WG con-
cluded that the findings and arguments pre-
sented were insufficient to support any claim 
that additives do not enhance the addictiveness 
and/or attractiveness of tobacco products. Con-
versely, the notion that substances added to ciga-
rettes enhance the sensory attributes of cigarette 
smoke and have pharmacological effects that 
encourage and stimulate smoking initiation and 
maintenance is not only scientifically plausible, 
but also supported by the findings highlighted 
by tobacco companies’ reports. Documents re-
leased through litigation (Legacy Tobacco Doc-
uments Library at the University of California; 
http://www.legacy.library.ucsf.edu) reveal that 
tobacco companies were engaged in an extensive 
research effort to develop products that enhance 
or maintain nicotine delivery, increase addic-
tiveness, improve taste and attenuate the harsh-
ness of tobacco smoke, thereby encouraging and 
stimulating smoking initiation and maintenance.
The burden of proof lies with the tobac-
co companies who have the responsibility to 
provide concrete scientific evidence produced 
through methodologically sound studies to 
demonstrate that additives do not enhance prod-
uct addictiveness and/or attractiveness. Based 
on the best available evidence, it is fair to say that 
tobacco additives reduce the harshness of tobac-
co smoke and make cigarettes more attractive to 
consumers, thereby encouraging and stimulat-
ing smoking initiation and maintenance. A dras-
tic reduction in smoking rates and progressive 
significant improvements in public health are 
therefore expected as ANVISA’s decision to ban 
tobacco additives is enforced.
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